David Roman

Stock Analyst

(n/a)
# 4,642
Out of 4,650 analysts
18
Total ratings
n/a
Success rate
n/a
Average return

Stocks Rated by David Roman

LivaNova
Oct 4, 2024
Initiates: Buy
Price Target: $65
Current: $53.16
Upside: +22.27%
iRhythm Technologies
Oct 4, 2024
Initiates: Neutral
Price Target: $78
Current: $76.30
Upside: +2.23%
Tandem Diabetes Care
Oct 4, 2024
Initiates: Neutral
Price Target: $46
Current: $32.75
Upside: +40.46%
Solventum
Aug 12, 2024
Maintains: Sell
Price Target: $48$54
Current: $73.36
Upside: -26.39%
Baxter International
Aug 8, 2024
Maintains: Neutral
Price Target: $36$40
Current: $36.01
Upside: +11.08%
Edwards Lifesciences
Jul 26, 2024
Maintains: Buy
Price Target: $107$91
Current: $68.52
Upside: +32.81%
Boston Scientific
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $84.76
Upside: +6.18%
Stryker
May 30, 2024
Initiates: Neutral
Price Target: $372
Current: $356.01
Upside: +4.49%
Intuitive Surgical
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $510.88
Upside: -2.13%
Abbott Laboratories
May 30, 2024
Initiates: Buy
Price Target: $121
Current: $114.07
Upside: +6.08%
Initiates: Buy
Price Target: $274
Current: $238.91
Upside: +14.69%
Initiates: Neutral
Price Target: $129
Current: $103.60
Upside: +24.52%
Initiates: Sell
Price Target: $83
Current: $90.60
Upside: -8.39%
Initiates: Neutral
Price Target: $87
Current: $85.93
Upside: +1.25%